Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Finasteride helps female-pattern hair loss.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

The combination treatment showed a higher response rate but no significant survival benefits.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

WYE-130600 may cause skin thickening and irritation.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Nano-liposome-bound EGF can delay hair growth in rats.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Targeting Keratin 17 may help overcome cancer therapy resistance.

ALRN-6924 may prevent hair loss caused by chemotherapy.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Entospletinib effectively prevents eye and skin GVHD in mice.

The treatment combination is effective and generally safe for lung cancer.

The treatment was ineffective in humans.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

EGF and FGF signaling stops hair follicle development in mice.

EGCG may help regrow hair by inhibiting a specific enzyme.

Topical rapamycin may effectively treat fibrous papules on the face.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.